FDA Recalls Eye Drop Medication Due to Contamination

The U.S. Food and Drug Administration (FDA) has announced a recall of Prednisolone Acetate Ophthalmic Suspension, USP, 1% by Lupin Pharmaceuticals Inc. The recall is due to the confirmed presence of a foreign substance in the eye drop medication. Further details regarding the recall are expected.